Frank Shafer Selected Research

Hemorrhage

12/2015	Nonacog alfa: an analysis of safety data from six prospective clinical studies in different patient populations with haemophilia B treated with different therapeutic modalities.
10/2013	Factors that influence the bleeding phenotype in severe hemophilic patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frank Shafer Research Topics

Disease

8	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 03/2024 - 01/2022
5	Fatigue 10/2023 - 01/2022
4	Hemolysis 03/2023 - 01/2022
3	Chronic Disease (Chronic Diseases) 10/2023 - 10/2022
2	Hemorrhage 12/2015 - 10/2013
2	Hemophilia A (Haemophilia) 05/2015 - 10/2013
1	Anemia 01/2023
1	Hypertension (High Blood Pressure) 01/2022
1	Rhinitis 01/2022
1	Raynaud Disease (Raynaud's Disease) 01/2022
1	Headache (Headaches) 01/2022
1	Hemophilia B (Haemophilia B) 12/2015
1	Inflammation (Inflammations) 10/2013
1	Joint Diseases (Joint Disease) 10/2013
1	Body Weight (Weight, Body) 10/2013

Drug/Important Bio-Agent (IBA)

8	sutimlimabIBA 03/2024 - 01/2022
4	Complement C1s (C1 Esterase)IBA 03/2023 - 01/2022
2	Hemoglobins (Hemoglobin)IBA 01/2023 - 01/2022
2	Factor IX (Coagulation Factor IX)FDA LinkGeneric 12/2015 - 10/2013
1	BilirubinIBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	recombinant factor VIII SQIBA 05/2015
1	Hemostatics (Antihemorrhagics)IBA 10/2013
1	Factor VIII (Coagulation Factor VIII)IBA 10/2013

Therapy/Procedure

3	Therapeutics 10/2023 - 10/2022